ArticleNature genetics2014
RHOA mutations in peripheral T cell lymphoma.
Article in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 20 citations in OpenAlex.
- Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma.Blood advances · 2025Article
- Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment.Frontiers in oncology · 2023Review
- The DNA-helicase HELLS drives ALKCell death & disease · 2021Article
- Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma.Scientific reports · 2020Article
- Whole-blood dysregulation of actin-cytoskeleton pathway in adult spinal muscular atrophy patients.Annals of clinical and translational neurology · 2020Article
- Review
- Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways.Blood cancer journal · 2018Review
- The Genetic Basis of Hepatosplenic T-cell Lymphoma.Cancer discovery · 2017Article
- Article
- Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.Cancer research · 2016Article
- The RhoA-ROCK pathway in the regulation of T and B cell responses.F1000Research · 2016Review
- Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression.The Journal of clinical investigation · 2015Article
- TET proteins and the control of cytosine demethylation in cancer.Genome medicine · 2015Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral T cell lymphomas are rare but aggressive non-Hodgkin lymphomas derived from mature T lymphocytes or natural killer (NK) cells. New studies identify recurrent dominant-negative mutation of the RHOA GTPase gene in these lymphomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.